Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1669 of 6351
-
New shot for kids with Crohn's or colitis shows promise in phase 3 trial
Disease control Recruiting nowThe main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) processes vedolizumab (pharmacokinetics) given just under the skin subcutaneously (SC). The participants will be treated …
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a malaria drug help fight HPV in women with HIV?
Disease control CompletedThe objective of this randomized, placebo-controlled trial is to evaluate whether intravaginal artesunate pessaries (vaginal inserts) can be used as adjuvant therapy following thermal ablation to improve Human papillomavirus (HPV) treatment outcomes in Women Living with Human Imm…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug shows promise for rare muscle diseases
Disease control Recruiting nowThe purpose of this study is to understand how the study medicine, dazukibart, works in people with active idiopathic inflammatory myopathies (dermatomyositis \[DM\] or polymyositis \[PM\]). Idiopathic inflammatory myopathies are a group of disorders that show inflammation of th…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a gut bug help heal fatty liver? new trial begins
Disease control OngoingMetabolic dysfunction-associated steatotic liver disease (MASLD), redefined in 2020, is an improved diagnostic standard evolved from non-alcoholic fatty liver disease (NAFLD), emphasizing the correlation between hepatic steatosis and metabolic dysfunction. Compared to NAFLD, whic…
Phase 1 • Sponsor: Leeuwenhoek Laboratories Co. Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A digital coach for hunger: can an app retrain appetite to improve diabetes control?
Disease control OngoingThe purpose of this 6-month randomized clinical trial is to examine the feasibility of recruitment, attendance, retention, program adherence, and satisfaction of a digital application designed, Centering Appetite to improve glucose scores (HbA1c) and binge eating in African Ameri…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a sixth day of radiation beat cancer recurrence?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New cocktail of cancer drugs aims to shrink tumors in advanced breast cancer
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in adults. To explore the reasonable dosage of dexmedetomidine hydrochloride nasal spray for preoperative sedation.
Phase 1/2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
A Pre-Surgery Tune-Up: could it help older adults recover faster?
Symptom relief OngoingThe goal of this clinical trial is to examine if one month of general health optimization before surgery for kidney tumors can help participants recover more quickly from surgery. The optimization process is called prehabiliation, and will last one month. It consists of 1. A co…
Sponsor: Herlev and Gentofte Hospital • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New chemo cocktail aims to boost survival in elderly leukemia patients
Disease control OngoingAcute myeloid leukemia (AML) is the most common leukemia in China, with a high incidence in elderly patients (≥60 years), who comprise over half of all cases (median age \~68 years). Elderly AML patients have a poor prognosis and carry multiple high-risk factors, with a 5-year ov…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New heart valve device shows early promise in small study
Disease control OngoingA prospective, non-randomized, single-arm, multi-center study designed to evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis or failed surgical aortic bioprosthetic valves.
Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New dosing schedule could ease sickle cell treatment for kids
Disease control Recruiting nowThe purpose of this interventional, phase II, national, multicentric, non-randomised, open-label study is to evaluate the pharmacokinetics (PK), efficacy and safety of Hydroxycarbamide Paediatric dispersible tablets with a twice daily dosing regimen in children with Sickle Celle …
Phase 2 • Sponsor: Theravia • Aim: Disease control
Last updated Jun 26, 2026 17:45 UTC
-
New hope for advanced cancer: experimental drug SHR-1681 enters human trials
Disease control Recruiting nowThis study is an open-label, multicenter Phase I/II clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-1681 for injection in patients with advanced solid tumors.
Phase 1/2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Tailored chemo doses aim to cut severe side effects in digestive cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to establish guidelines for fluoropyrimidine dose reduction according to uracilemia in patients with DPD deficiency in the treatment of digestive cancers. The main question it aims to answer is: \- Which reduction dose of fluoropyrimidine is ne…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a smartphone app stop family violence? new study recruits 1,270 families to find out.
Prevention Recruiting nowThe Family Check-Up Online, a digital health intervention, was designed to improve child mental health through family-centered intervention. The Family Check-Up is grounded in over 25 years of evidence-based research and has been shown to improve child mental health and behavior …
Sponsor: University of Oregon • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
New hope for type 1 diabetes: can common diabetes drugs improve blood sugar control?
Disease control CompletedType 1 Diabetes (T1DM) is a disease characterised by immune mediated destruction of the insulin-producing pancreatic beta cells. Overtime, obvious insulin deficiency develops which requires insulin therapy. T1DM accounts for about 5% to 10% of diabetes cases in Europe and United …
Phase 2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a smarter breathing machine protect premature brains?
Knowledge-focused Recruiting nowThis is a prospective observational study investigating the impact of NIV-NAVA on short-term clinical outcomes and long-term neurodevelopment in very preterm infants.
Sponsor: Korea University Anam Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New study aims to predict which blockages need stenting after a heart attack
Knowledge-focused Recruiting nowMost heart attacks occur because a clot forms in a coronary artery blocking blood flow. Without blood heart muscle dies. Untreated, clots can cause a specific type of heart attack -ST-elevation myocardial infarction (STEMI). STEMI patients are treated immediately by finding the b…
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Could your own fat cells help control diabetes? new study investigates
Disease control Recruiting nowThis prospective clinical study aims to evaluate the safety and efficacy of autologous adipose-derived stromal vascular fraction (SVF), enriched with mesenchymal stem cells (ADSCs), for the treatment of Type 2 Diabetes Mellitus (T2DM). Adipose tissue will be harvested using a 12…
Sponsor: Kaiser Clinic and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Real-World check: does lorlatinib work for ALK lung cancer?
Disease control Recruiting nowAnalysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World context
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a common painkiller boost emergency contraception? new trial tests combo pill
Disease control Recruiting nowThe goal of this clinical trial is to compare the failure rate of the levonorgestrel (LNG)-piroxicam combination regimen versus ulipristal acetate (UPA) as emergency contraception (EC). The main questions it aims to answer are: 1. whether the LNG-piroxicam combination regimen ha…
Phase 3 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC